Vectron to buy protein production platform from T3S

By The Science Advisory Board staff writers

June 17, 2021 -- Vectron Biosolutions announced it recently raised $2.7 million and will buy a bacterial secretion platform from Utah-based T3S Technologies.

T3S's secretion platform is based on high-level expression followed by true secretion of proteins and will allow Vectron to boost its protein production offering, according to the company. Dynamk Capital, a growth equity and venture capital firm, led the financing round, Vectron said.


Copyright © 2021 scienceboard.net
 


Email Address:

First Name:

Last Name:

I have read and agree to the privacy policy and terms of service and wish to opt-in for ScienceBoard.net.